Skip to main content

Table 3 Demographic characteristics and clinical information of the stroke patients included in BOSC-based Stroke Registry Study

From: China stroke surveillance report 2021

Characteristics

IS (n = 118,425)

ICH (n = 14,708)

SAH (n = 3149)

Male [n (%)]

72,595 (61.3)

9354 (63.6)

1404 (44.6)

Age [years, median (IQR)]

68 (56–74)

63 (53–70)

57 (51–67)

Full expense [n (%)]

5684 (4.8)

1235 (8.4)

321 (10.2)

Patients with time from symptom onset to hospital arrival within 2 h [n (%)]

11,605 (9.8)

2427 (16.5)

636 (20.2)

Transported to hospital by EMS [n (%)]

8882 (7.5)

2868 (19.5)

712 (22.6)

Risk factors [n (%)]

 A history of stroke

14,211 (12.0)

2235 (15.2)

268 (8.5)

 Hypertension

81,121 (68.5)

11,501 (78.2)

1587 (50.4)

 DM

25,106 (21.2)

1691 (11.5)

334 (10.6)

 AF

4500 (3.8)

221 (1.5)

28 (0.9)

 TIA

13,619 (11.5)

1485 (10.1)

277 (8.8)

TOAST classification in ischemic stroke [n (%)]

 

 1-LAA

51,515 (43.5)

  

 2-CE

13,619 (11.5)

  

 3-SVO

36,949 (31.2)

  

 4-SOE

5329 (4.5)

  

 5-SUE

11,014 (9.3)

  

Severity at admission [median (IQR)]

 NIHSS or GCS score

3 (1–5)

12 (8–15)

13 (10–15)

 mRS score

1 (1–3)

3 (1–4)

2 (1–4)

Intravenous thrombolysis [n (%)]

6394 (5.4)

DNT [min, median (IQR)]

44 (27–64)

ONT [min, median (IQR)]

166 (145–202)

Thrombolytic complications

908 (14.2)

  

 Intracranial hemorrhage

192 (3.0)

  

Endovascular therapy [n (%)]

1539 (1.3)

 Recanalization rate

1248 (81.1)

  

 Complications

228 (14.8)

  

 Intracranial hemorrhage

105 (6.8)

  

Craniotomy treatment [n (%)]

1544 (10.5)

1064 (33.8)

Stereotactic treatment [n (%)]

471 (3.2)

765 (24.3)

Antiplatelet therapy for noncardiac stroke [n (%)]

82,564 (78.8) *

  

Swallowing function assessment rate [n (%)]

85,858 (72.5)

4457 (30.3)

929 (29.5)

Rehabilitation rate [n (%)]

71,529 (60.4)

7383 (50.2)

1622 (51.5)

Length of stay [d, median (IQR)]

12 (9–15)

13 (10–16)

14 (10–17)

Hospitalization costs/patient [CNY, median (IQR)]

16,004 (7484–19,767)

18,439 (9898–34,567)

79,598 (19,726–142,085)

Severity at discharge-mRS score [median (IQR)]

1 (0–2)

2 (1–4)

1 (0–3)

In-hospital mortality {n [ % (95% CI)]}

947 [0.8 (0.8–0.9)]

677 [4.6 (4.3–4.9)]

139 [4.4 (3.9–5.1)]

  1. *n = 104,806
  2. IS ischemic stroke, ICH intracerebral hemorrhage, SAH subarachnoid hemorrhage, IQR interquartile range, BMI body mass index, EMS Emergency Medical Services, LAA large artery atherosclerosis, SVO small vessel occlusion, CE cardioembolism, SOE stroke of other determined etiology, SUE stroke of undetermined etiology, NIHSS NIH Stroke Scale score, DNT Door to Needle Time, ONT Onset to Needle Time, CNY Chinese Yuan, GCS Glasgow Coma Scale, mRS modified Rankin Scale, TIA transient ischemic attack, DM diabetes mellitus, AF atrial fibrillation